334 related articles for article (PubMed ID: 25188404)
21. Identification of Transcribed Enhancers by Genome-Wide Chromatin Immunoprecipitation Sequencing.
Blinka S; Reimer MH; Pulakanti K; Pinello L; Yuan GC; Rao S
Methods Mol Biol; 2017; 1468():91-109. PubMed ID: 27662872
[TBL] [Abstract][Full Text] [Related]
22. Predicting enhancer transcription and activity from chromatin modifications.
Zhu Y; Sun L; Chen Z; Whitaker JW; Wang T; Wang W
Nucleic Acids Res; 2013 Dec; 41(22):10032-43. PubMed ID: 24038352
[TBL] [Abstract][Full Text] [Related]
23. Current Advances on the Important Roles of Enhancer RNAs in Molecular Pathways of Cancer.
Wang R; Tang Q
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073237
[TBL] [Abstract][Full Text] [Related]
24. Noncoding RNAs and enhancers: complications of a long-distance relationship.
Orom UA; Shiekhattar R
Trends Genet; 2011 Oct; 27(10):433-9. PubMed ID: 21831473
[TBL] [Abstract][Full Text] [Related]
25. A large fraction of extragenic RNA pol II transcription sites overlap enhancers.
De Santa F; Barozzi I; Mietton F; Ghisletti S; Polletti S; Tusi BK; Muller H; Ragoussis J; Wei CL; Natoli G
PLoS Biol; 2010 May; 8(5):e1000384. PubMed ID: 20485488
[TBL] [Abstract][Full Text] [Related]
26. HeRA: an atlas of enhancer RNAs across human tissues.
Zhang Z; Hong W; Ruan H; Jing Y; Li S; Liu Y; Wang J; Li W; Diao L; Han L
Nucleic Acids Res; 2021 Jan; 49(D1):D932-D938. PubMed ID: 33119754
[TBL] [Abstract][Full Text] [Related]
27. Identification and Functional Characterization of Two Noncoding RNAs Transcribed from Putative Active Enhancers in Hepatocellular Carcinoma.
Lee YE; Lee J; Lee YS; Jang JJ; Woo H; Choi HI; Chai YG; Kim TK; Kim T; Kim LK; Choi SS
Mol Cells; 2021 Sep; 44(9):658-669. PubMed ID: 34588321
[TBL] [Abstract][Full Text] [Related]
28. Spirits in the Material World: Enhancer RNAs in Transcriptional Regulation.
Hou TY; Kraus WL
Trends Biochem Sci; 2021 Feb; 46(2):138-153. PubMed ID: 32888773
[TBL] [Abstract][Full Text] [Related]
29. Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential.
Lee JH; Xiong F; Li W
RNA Biol; 2020 Nov; 17(11):1550-1559. PubMed ID: 31916476
[TBL] [Abstract][Full Text] [Related]
30. Epigenomics of macrophages.
Gosselin D; Glass CK
Immunol Rev; 2014 Nov; 262(1):96-112. PubMed ID: 25319330
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer.
Zhang Z; Lee JH; Ruan H; Ye Y; Krakowiak J; Hu Q; Xiang Y; Gong J; Zhou B; Wang L; Lin C; Diao L; Mills GB; Li W; Han L
Nat Commun; 2019 Oct; 10(1):4562. PubMed ID: 31594934
[TBL] [Abstract][Full Text] [Related]
32. Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs.
Hah N; Benner C; Chong LW; Yu RT; Downes M; Evans RM
Proc Natl Acad Sci U S A; 2015 Jan; 112(3):E297-302. PubMed ID: 25564661
[TBL] [Abstract][Full Text] [Related]
33. Large-scale discovery of enhancers from human heart tissue.
May D; Blow MJ; Kaplan T; McCulley DJ; Jensen BC; Akiyama JA; Holt A; Plajzer-Frick I; Shoukry M; Wright C; Afzal V; Simpson PC; Rubin EM; Black BL; Bristow J; Pennacchio LA; Visel A
Nat Genet; 2011 Dec; 44(1):89-93. PubMed ID: 22138689
[TBL] [Abstract][Full Text] [Related]
34. Altered enhancer transcription underlies Huntington's disease striatal transcriptional signature.
Le Gras S; Keime C; Anthony A; Lotz C; De Longprez L; Brouillet E; Cassel JC; Boutillier AL; Merienne K
Sci Rep; 2017 Feb; 7():42875. PubMed ID: 28225006
[TBL] [Abstract][Full Text] [Related]
35. Pig-eRNAdb: a comprehensive enhancer and eRNA dataset of pigs.
Wang Y; Jin W; Pan X; Liao W; Shen Q; Cai J; Gong W; Tian Y; Xu D; Li Y; Li J; Gong J; Zhang Z; Yuan X
Sci Data; 2024 Feb; 11(1):157. PubMed ID: 38302497
[TBL] [Abstract][Full Text] [Related]
36. Chromatin state signatures associated with tissue-specific gene expression and enhancer activity in the embryonic limb.
Cotney J; Leng J; Oh S; DeMare LE; Reilly SK; Gerstein MB; Noonan JP
Genome Res; 2012 Jun; 22(6):1069-80. PubMed ID: 22421546
[TBL] [Abstract][Full Text] [Related]
37. Enhancers as non-coding RNA transcription units: recent insights and future perspectives.
Li W; Notani D; Rosenfeld MG
Nat Rev Genet; 2016 Apr; 17(4):207-23. PubMed ID: 26948815
[TBL] [Abstract][Full Text] [Related]
38. Enhancer transcripts mark active estrogen receptor binding sites.
Hah N; Murakami S; Nagari A; Danko CG; Kraus WL
Genome Res; 2013 Aug; 23(8):1210-23. PubMed ID: 23636943
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNAs and enhancers.
Ørom UA; Shiekhattar R
Curr Opin Genet Dev; 2011 Apr; 21(2):194-8. PubMed ID: 21330130
[TBL] [Abstract][Full Text] [Related]
40. Rapid and pervasive changes in genome-wide enhancer usage during mammalian development.
Nord AS; Blow MJ; Attanasio C; Akiyama JA; Holt A; Hosseini R; Phouanenavong S; Plajzer-Frick I; Shoukry M; Afzal V; Rubenstein JL; Rubin EM; Pennacchio LA; Visel A
Cell; 2013 Dec; 155(7):1521-31. PubMed ID: 24360275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
